Your pharmaceutical innovation partner based on adipose tissue

DIVA Expertise provides advanced adipose tissue models to evaluate your molecules’ impact on energy balance, immunity, and system interactions. From preclinical testing to drug repositioning, we help you identify promising candidates faster, reduce risks, and accelerate targeted, effective therapies.

Pharmaceutical innovation based on adipose tissue

Accelerating pharmaceutical innovation against Obesity and Metabolic disorders

Models for pharmaceutical innovation

Over 1 billion people worldwide are affected by obesity and metabolic disorders, a number set to double by 2040.

Adipose tissue is not only central to energy balance but also a key endocrine organ. Its dysfunction drives insulin resistance, obesity, type 2 diabetes, dyslipidemia, and cardiovascular complications.

DIVA Expertise provides advanced preclinical adipose tissue models to investigate adipose biology and accelerate the development of targeted therapies, including GLP-1 modulators.

Adipose Tissue: A central player in human endocrine health

DIVA’s innovative models for comprehensive pharmaceutical research

Metabolic disorders

Inflammatory diseases

Skin health & dermatology

Aging & Inflammaging

Cross-talk with other organs

Discover our innovative adipose tissue models
to evaluate and highlight efficacy of your pharmaceutical products

Do you need to screen/explore effect for pharmaceutical target or treatment?

Give us more details about your needs.

 

Please share details about your pharmaceutical product and your study goals.

For example, you may want to evaluate your product’s efficacy in human adipose tissue models, compare responses across donor populations, or explore its mechanisms of action.

Our team will work closely with you to support your research or product need and deliver reliable, human-relevant insights.

GDPR conditions

Sources : Vigouroux C., Basdevant A. Obepi-Roche 2020 : Évolution de la prévalence de l’obésité en France. Journal of Clinical Medicine, 2023; 12(3): 925. DOI: 10.3390/jcm12030925.
Rapport d’information n° 744 (2020-2021) du Sénat sur la prévention et la prise en charge de l’obésité. 
Disponible sur : https://www.senat.fr/rap/r21-744/r21-744_mono.html

Do you have a question about the potential of human adipose tissue for your research?


Our team of experts will be happy to answer all your askings.

DIVA Expertise
1 Pl. Pierre Potier, 31100 Toulouse FRANCE
 +33 5 34 56 46 80

Do you have a question about the potential of human adipose tissue for your research?

Our team of experts will be happy to answer all your askings.